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Abstract
Background. Urinary tract infection (UTI) is common infection feature 
worldwide. Infected patients are usually treated empirically treated 
without culture or antibiotics susceptibility testing, and which may 
lead to increase antibiotic resistance level. This study aims to deter-
mine the prevalence and antibiotic susceptibility patterns of common 
uropathogenic bacteria isolated at Youssef Hospital Center, Akkar gov-
ernorate, North of Lebanon.
Methods. Spot midstream of urine samples from 9662 patients with 
UTI symptoms who came for medical investigation to Youssef Hospital 
Center located in Akkar governorate. Urine specimens were collected 
in sterile plastic bottles. Culture, identification and antibiotic suscep-
tibility testing were performed using conventional tools according to 
the recommendations of the European Committee on Antimicrobial 
Susceptibility Testing.
Results. A total of 1009 bacterial uropathogens were isolated. Escheri-
chia coli was most presented (72.5%) of all isolates, followed by Kleb-
siella pneumoniae (8.2%), Enterococcus spp. (5.5%), Pseudomonas 
aeruginosa (4.5%), Proteus spp. (3%), Enterobacter spp. (2%), Staphy-
lococcus aureus (2%), Streptococcus agalactiae (1.6%), Staphylococcus 
saprophyticus (0.4%), Acinetobacter baumannii (0.2%) and Providen-
cia rettgeri (0.1%). Moreover, the mean antibiotic resistance rates of 
isolates was relatively high, but comparable to previously published 
data in Lebanon.
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Introduction
 
Urinary tract infections (UTIs) are the most com-
mon infections in humans that can affect any part of 
the urinary system including kidneys, ureters, blad-
der, or urethra. It is estimated that approximately 
150 million cases occur yearly globally each year 
[1]. Clinically, UTI is categorized as uncomplicated 
or complicated cases. Uncomplicated UTIs occur in 
healthy individuals and usually can be cured within 
3 days of treatment. These infections are more com-
mon causing cystitis (lower UTI) and pyelonephritis 
(upper UTI) [2,3]. Numerous risk factors can increase 
the likelihood of developing a UTI, including female 
gender, sexual intercourse, poor personal hygiene, 
diabetes, obesity, vaginal infections and heavy use 
of antibiotics [4]. In contrast, complicated UTIs are 
found in an individual with factors that compro-
mise the urinary tract or immune system, such as 
immunosuppression, renal failure, renal transplanta-
tion, pregnancy, problems of emptying the blad-
der completely, kidney stones and the presence of 
foreign bodies particularly indwelling catheters [5]. 
Additionally, this type of UTI requires longer periods 
of antibiotic treatment [6].
The leading pathogens of UTIs are caused mainly 
by Gram-negative bacteria including uropathogenic 
Conclusion. To the best of our knowledge, this is the first investi-
gation reporting epidemiological data regarding the prevalence and 
antibiotic susceptibility patterns of bacterial uropathogens isolated 
from patients in the Akkar governorate. Our data indicated the urgent 
need of a strategic plan to tackle antibiotic resistance, particularly in 
deprived regions with poor healthcare centers. 
Keywords: Uropathogens, Epidemiology, Antibiotic susceptibility, Risk 
factors, Akkar governorate, North Lebanon.
Escherichia coli (E. coli), Klebsiella pneumoniae (K. 
pneumoniae), Proteus mirabilis and Pseudomonas 
aeruginosa (P. aeruginosa). Gram-positive bacteria 
like S. aureus, Staphylococcus saprophyticus (S. sap-
rophyticus), Enterococcus faecalis (E. faecalis) and 
Streptococcus agalactiae (S. agalactiae), and yeasts 
like Candida spp. are also an important cause of 
UTIs [1].
Recently, The Center for Disease Control and 
Prevention (CDC) declared that the human race is 
now in the post-antibiotic era [7]. The World Health 
Organization (WHO) also warned that the antibiotic 
resistance crisis is becoming serious all around the 
world [7]. In the past decade in Lebanon, several 
recent studies documented the occurrence of high 
rates of antibiotic resistant bacteria [8-21]. However, 
no data was reported from the Akkar governorate 
located in North of Lebanon. Akkar covers 788 km2 
of territory and is one of the most deprived regions 
in Lebanon. It shows all the typical features of a 
poor and relatively isolated rural community, with 
bad infrastructure and low quality of education and 
health services.
For this reason, we conducted this investigation 
in order to determine for the first time the preva-
lence of bacterial pathogens causing UTIs and their 
antibiotic susceptibility profiles of isolates from pa-
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tients in Youssef hospital center in the Akkar gov-
ernorate, North of Lebanon.
Material and Methods
This study was conducted in the clinical micro-
biology laboratory of Youssef hospital center in the 
Akkar governorate during the period from Septem-
ber 2015 to January 2017. This hospital created in 
1995, contains 120 beds available to deliver high-
quality patient care in one center. Spot midstream 
of urine samples were collected from 9662 patients 
presenting with UTI symptoms. The sterile urine 
specimens transported immediately to the micro-
biology department. The count of white bloodcells 
(WBC) was carried out on centrifuged urine speci-
mens using routine microscopy. Culture of uncentri-
fuged specimens was performed using a calibrated 
loop (10 µl) on UriSelect™ 4 agar (Bio-Rad®, France) 
after an incubation for 18 to 24 hours at 35°C. The 
bacterial identification was performed according to 
the manufacturer’s recommended procedures and 
through the use of API-20E and API-20NE (bioMé-
rieux® - France), Pastorex™ Staph Plus kit (Bio-Rad®, 
France), and Pastorex™ Strep kits (Bio-Rad®, France).
The antibiotic susceptibility testing was performed 
by the disk diffusion method on Mueller Hinton agar 
for Enterobacteriaceae and non-Enterobacteriaceae 
Gram negative rods, Staphylococcus spp., Enterococ-
cus spp. (Bio-Rad®, France), and on Mueller Hinton 
agar supplemented with 5% blood and 20 mg/l 
β-NAD (MHF) for S. agalactiae according to the rec-
ommendations of the European Committee on An-
timicrobial Susceptibility Testing (EUCAST).
In addition, statistical analyses were performed 
with GraphPad Prism 6.0 (GraphPad Software Inc., 
SanDiego, CA) using the Fisher’s exact test to ex-
plorethe association between gender and infection, 
and betweenthe sex ratio (male/female) and the age 
of infected patients (<70 years and ≥70 years). The 
general significance level was set at a P-value below 
0.05.
Results
A total of 9662 consecutive urine samples were 
included in our study. Of these, 8653 (89.6%) were 
negative for the growth of bacteria or showed insig-
nificant growth, and 1009 (10.4%) were positive for 
significant bacterial growth. Among positive sam-
ples, 244 belonged to males and 765 belonged to 
females, ranging in age from 1 month to 97 years, 
with a mean age of 47.5 years. All the patients 
came from the Akkar governorate. Moreover, the 
positive patients had more than 200 white blood 
cells/mm3 in their urine specimens as determined 
by routine microscopy. E. coli caused the highest 
infection rate (72.5%), followed by K. pneumoniae 
(8.2%), Enterococcus spp. (5.5%), P. aeruginosa 
(4.5%), Proteus spp. (3%), Enterobacter spp. (2%), 
S. aureus (2%), S. agalactiae (1.6%), S. saprophyti-
cus (0.4%), Acinetobacter baumannii (A. baumannii) 
(0.2%) and Providencia rettgeri (P. rettgeri) (0.1%). 
Tables 1 and 2 express distribution of the major 
bacterial isolates based age and sex of patients, 
respectively.The mean sex ratio (male/female) of 
infection was 0.32. The sex ratio (male/female) of 
urine infections showed the lower rates among the 
children and younger populations and the higher 
rates among older populations, particularly in pa-
tients aged more than 70 years  In ad-
dition, according to EUCAST guidelines, the mean 
percentages of susceptibility of Gram-negative and 
Gram-positive isolates are showed in Table 3, 4 
and 5, respectively.
Discussion
To our best knowledge, the present study rep-
resents the first investigation from a hospital in 
the Akkar governorate, North of Lebanon. In addi-
tion, no data is available in the literature regarding 
to the distribution of bacterial uropathogens and 
their antibiotic resistance patterns in this region. 
Hence, this investigation provides important labo-
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Table 1. Distribution of the isolatedbacterial strains according to the age of patients
Age class
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[0-10] 0.21 139 7 6 3 0 6 1 13 1 1 0
[10-20] 0.12 21 1 2 1 0 0 0 1 2 0 0
[20-30] 0.11 73 15 4 3 0 9 0 6 8 0 3
[30-40] 0.09 59 7 4 0 0 4 0 7 1 1 2
[40-50] 0.40 51 3 1 2 0 10 0 0 1 0 2
[50-60] 0.35 74 8 1 2 0 4 0 6 2 0 3
[60-70] 0.35 99 14 2 2 0 2 0 6 1 0 2
[70-80] 0.55 120 15 4 7 0 4 0 10 1 1 2
[80-90] 0.69 79 11 4 0 1 3 1 5 3 1 2
[90-100] 0.65 17 2 2 0 0 3 0 2 0 0 0
Total 0.32 732 83 30 20 1 45 2 56 20 4 16
Table 2. Distribution of the isolated bacterial strains according to the sex of patients and inpatient/
outpatient status
Bacteria Male Female
Sex ratio (male/
female)
Inpatient 
status
Outpatient 
status
Total (%)
E. coli 154 578 0.27 475 257 732 (72.5%)
K. pneumoniae 17 66 0.26 62 21 83 (8.2%)
Proteus spp. 10 20 0.5 13 17 30 (3%)
Enterobacter spp. 5 15 0.33 15 5 20 (2%)
P. aeruginosa 25 20 1.25 33 12 45 (4.5%)
Enterococcus spp. 21 35 0.6 30 26 56 (5.5%)
S. aureus 5 15 0.33 9 11 20 (2%)
S. agalactiae 4 12 0.33 9 7 16 (1.6%)
Others 3 4 0.75 4 3 7 (0.7%)
Total 244 765 0.32 650 359 1009
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ratory data that could support national surveillance 
of antibiotic resistance and will improve treatment 
recommendations in this geographical region of our 
country. Overall, a total of 1009 isolates were col-
lected from Akkari patients. The majority of urine 
infection cases were found in female (765/1009). 
A significant gender difference in the prevalence 
of the infection was found (OR: 3.5 CI: 3.0–4.1, 
P<0.0001) as reported in other study [1].Women, 
particularly sexually active and aged between 16 
and 64 years have significantly more risk to experi-
ence UTIs than men because they have a shorter 
urethra [22]. However, UTIs often occur in both 
genders and across all age groups, including elderly 
population [23]. In the same context, the sex ratio 
(male/female) has significantly increased with age, 
particularly in patients older than 70 years (OR: 2.6 
CI: 1.9–3.5, P<0.0001). Older adults are associated 
with high burden of UTI and need improvement in 
diagnosis and treatment of their infections. Accord-
ing to our laboratory records, E. coli was the most 
common pathogen causing UTIs, followed by other 
well-known uropathogens; K. pneumoniae, Proteus 
spp, Enterobacter spp. and P. aeruginosa (Table 3) 
and these results are comparable to other studies 
from various countries [22,24]. No significant dif-
ference was found concerning the distribution of 
uropathogens according to age of patients. All types 
of bacterial pathogens were found in both females 
and males. However, out of all P. aeruginosa iso-
lates, 13 (28.9%) were from hospitalized patients. 
This organism is becoming an important cause of 
UTI associated with hospital-acquired UTIs [1]. 
Furthermore, this investigation showed a relative-
ly high antibiotic resistance rates among the major-
ity of uropathogens isolated in our hospital (Tables 
3-5). E. coli isolates showed high level of resistance 
to commonly used empirical antibiotics such asbeta-
lactams, quinolones and trimethoprim/sulfamethox-
azole. In the present study, 35.7% of E. coli isolates 
were ESBL-producers. Our findings showed similar 
percentages of resistance to antibiotics described 
in previous studies conducted in Lebanon. Numer-
ous recent investigations found a high prevalence 
of ESBL-producing E. coli [8,15,25]. Moreover, we 
found that resistance to ertapenem, imipenem and 
Figure 1. The variation of the sex ratio (male/female) according to the age of infected patients.
***
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Table 3. Percentage of antibiotic susceptibility of major Gram-negative bacilli isolates.
E.coli
N=732
(%)
K. pneumoniae
N=83
(%)
Proteus spp.
N=30
(%)
Enterobacter spp.
N=20
(%)
P. aeruginosa
N=45
(%)
AMP 26.2 0 30 0 -
AMC 79.6 89.2 83.3 0 -
TIC 29.2 0 40 85 64.4
TCC 82.0 86.7 93.3 90 64.4
PIP 29.2 0 40 85 64.4
PPT 90.7 90.4 93.3 95 64.4
CFX 50.5 68.7 70 0 -
CXM 53.3 68.7 70 85 -
FOX 84.2 95.2 83.3 0 -
CFM 57.9 71.1 80 90 -
CTX 60.1 71.1 83.3 90 -
CAZ 63.3 73.5 83.3 90 71.1
FEP 68.6 75.9 90 95 71.1
ATM 62.7 72.3 90 90 -
ERT 98.9 98.8 100 95 -
IMP 99.6 100 100 100 60
MEM 99.6 100 100 100 60
GMN 80.1 77.1 66.7 100 93.3
TMN 73.4 74.7 63.3 95 93.3
NET 99.6 98.8 76.7 100 95.6
AKN 99.3 100 90 100 93.3
NA 45.5 71.1 46.7 90 -
NXM 60.5 74.7 53.3 95 -
CIP 61.7 74.7 56.7 95 53.3
LVX 61.7 79.5 56.7 95 53.3
TGC 99.9 - - - -
CS 100 100 0 100 100
FSF 98.9 92.8 66.7 75 88.9
FUR 99.3 89.2 0 85 -
SXT 55.7 55.4 43.3 80 -
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meropenem was about 1.1%, 0.4% and 0.4%, 
respectively. Several recent studies reported the 
emergence carbapenem-resistance strains in North 
of Lebanon, mainly by OXA-48 production [25-30]. 
Gentamicin and ciprofloxacin resistance were about 
19.9% and 38.3%, respectively, which are in the 
range of previous community based studies in Leba-
non [8,15,18,25]. Regarding to the other isolated 
Enterobacteriaceae, the resistance rate was lower 
than that observed in E. coli isolated isolates, except 
with Proteus spp. which had the highest resistance 
rate between isolates of Enterobacteriaceae to fluo-
roquinolones, with 46.7% to norfloxacin, 43.3% 
to ciprofloxacin and 43.3% to levofloxacin. Fur-
thermore, this study showed a trend of increasing 
resistance in P. aeruginosa isolates to all commonly 
used antibiotic agents. P. aeruginosa resistance to 
carbapenem and fluoroquinolones was 40% and 
46.7%, higher than the previous rates of (8.7% to 
28.5% and 8.7 to 20%, respectively) which was 
reported in other studies [8,13]. The rise in carbape-
nem resistance could be the result of increasing use 
of carbapenem and which is associated with spread 
of ESBL-producing strains in the last few years in 
Lebanon [8]. In the same context, the increase of 
fluoroquinolone resistance could be explained by 
the misuse and overuse of this class of antibiotics 
in the Middle East region.
Among Gram-positive cocci isolates, Enterococ-
cus spp. was the predominant, followed by S. au-
reus, S. agalactiae, and S. saprophyticus 
The susceptibility of Enterococcus spp. to ampicillin 
and imipenem was equal to 73.2%. High level of 
resistance was recorded to trimethoprim/sulfameth-
oxazole, tetracycline, ampicillin, imipenem, erythro-
mycin and fluoroquinolones (Table 5). No vanco-
mycin-resistant enterococci was observed in our 
study. During the last decade, limited studies were 
done dealing with the identification of Enterococ-
cus spp. circulating in Lebanon and their antibiotic 
resistance patterns. A recent study in Lebanon has 
showed that among 53 Enterococcus spp. isolates, 
E. faecalis was predominant (72.5%), followed by 
Enterococcus faecium (22.9%), Enterococcus avium 
(3.3%) and Enterococcus gallinarum (1.3%) [31].
With regard to S. aureus, the clinical significance 
of a positive urine culture for this pathogen is still 
unclear. Recent studies have reported that S. au-
reus can cause approximately 0.5 to 6% of UTIs 
[32]. The prevalence of methicillin-resistant S. aureus 
Table 4. Percentage of antibiotic susceptibility of 
ESBL-producing isolates.
E. coli
N=261
(%)
K. pneumoniae
N=23
(%)
Proteus spp.
N=4
(%)
AMP 0 0 0
AMC 82.4 95.7 100
TIC 0 0 0
TCC 75.1 82.6 100
PIP 0 0 0
PPT 88.9 95.7 100
CFX 0 0 0
CXM 0 0 0
FOX 85.4 95.7 100
CFM 2.7 4.3 25
CTX 1.9 0 0
CAZ 13 13 25
FEP 16.9 17.4 25
ATM 8 8.7 25
ERT 100 100 100
IMP 100 100 100
MEM 100 100 100
GMN 58.6 34.8 25
TMN 43.3 21.7 25
NET 99.6 100 25
AKN 99.6 100 25
NA 20.3 30.4 25
NXM 34.5 34.7 25
CIP 35.2 34.7 25
LVX 35.2 47.8 25
TGC 100 - -
CS 100 100 0
FSF 98.1 87 50
FUR 100 91.3 0
SXT 36 8.7 0
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(MRSA), based on cefoxitin resistance was higher 
than that reported in nasal secretions of healthy 
school children in Tripoli, north of Lebanon [33]. In 
addition, Chamoun et al. [8] reported an increase 
in the prevalence of MRSA between 2011 and 2013 
in Lebanese hospitals. Therefore, there is urgent 
need to control and prevent transmission of MRSA 
infections in hospitalized patients. Contamination 
through MRSA frequently occurs by direct skin-to-
skin contact or shared items and is often associated 
with poor hygiene practices in hospitals [34]. How-
ever, all S. aureus isolates in our study were suscep-
tible to vancomycin, teicoplanin and linezolid. Con-
cerning S. agalactiae isolates, 100% susceptibility 
rate was observed to penicillin, vancomycin, teico-
planin, pristinamycin, tigecycline and nitrofurantoin, 
and high susceptibility rates were demonstrated to 
fluoroquinolones and rifampicin, respectively (Ta-
ble 5). High levels of resistance were also recorded 
to tetracycline, trimethoprim/sulfamethoxazole, and 
less to erythromycin and clindamycin (Table 5). 
These findings are higher than the respective rates 
reported previously in our country [31].
Overall, our data indicate that antibiotic resistance 
rates of bacterial uropathogens are relatively high 
in the Akkari patients, and are much comparable 
to previous community based studies conducted in 
Lebanon. The increase in antibiotic resistance rates 
is now becoming a major problem in the Akkar 
Governorate as well as in the whole country. High 
resistant rates among uropathogenic bacteria will 
certainly contribute to antibiotic selective pressures, 
maintain and spread of resistant strains in our com-
munity. Additionally, antibiotic selective pressure is 
usually linked to high spread of counterfeit medi-
cines, misuse and overuse of antibiotics. 
In conclusion, a national strategic plan is urgently 
needed to combat antibiotic resistance in all regions 
of Lebanon. A good antibiotic stewardship plan 
should aim to ensure the appropriate use of anti-
biotics and reduce the risk of infection with drug-
resistant organisms. 
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N=20
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